Efficacy and Safety of SPARC0921 in Subjects With Spasticity
- Registration Number
- NCT01457352
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Brief Summary
The purpose of this study is to assess whether SPARC0921 demonstrate efficacy and safety in the treatment of spasticity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 392
- Men and women age 18 years and older
- Able and willing to comply with the protocol, including availability for a scheduled clinic visits
- Willingness and giving of written informed consent
- In relapse or history of unstable course over the prior 30 days prior to the Screening Visit
- Concomitant neurologic conditions causing spasticity
- Has received an investigational drug or device within 30 days that would interfere with the study goals prior to the Screening Visit
- Unable to comply with study procedures in the opinion of the investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo0921 Placebo0921 - SPARC0921 SPARC0921 -
- Primary Outcome Measures
Name Time Method Treatment Failure Rate Week 22 Percentage of subjects who had treatment failure Clinical Global Impression of Change of β₯ 5 and at least one movement with β₯ 1 unit increase in modified Ashworth score from baseline.
The modified Ashworth scale is a 6-point scale as follows: Minimum score of 0 (better outcome) = no increase in tone Maximum score of 4 (worst outcome) = affected part(s) rigid inflexion or extension.
The clinician (other than the one performing the Modified Ashworth Scale assessment) rated his/her overall (global) impression of change in spasticity using the 7-point scale shown below: Minimum score of 1 (better outcome) = very much improved Maximum score of 7 (very much worse) = very much worse
- Secondary Outcome Measures
Name Time Method Severity of Spasticity Assessed by Subject Global Impression Severity Scale Week 22 The subject was asked "Overall, how would you rate the severity of your spasticity over the past 24 hours?" The 7-point scale for Subject's global impression of severity assessment is as follows: minimum score of 1 = normal, no spasticity maximum score of 7 (worst outcome)= worst spasticity imaginable
Trial Locations
- Locations (73)
SPARC Site 56
πΊπΈColumbus, Ohio, United States
SPARC Site 17
πΊπΈPort Charlotte, Florida, United States
SPARC Site 36
πΊπΈCosta Mesa, California, United States
SPARC Site 20
πΊπΈNewport Beach, California, United States
SPARC Site 15
πΊπΈBradenton, Florida, United States
SPARC Site 19
πΊπΈSarasota, Florida, United States
SPARC Site 30
πΊπΈOverland Park, Kansas, United States
SPARC Site 76
π©πͺErbach, Germany
SPARC Site 43
πΊπΈHouston, Texas, United States
SPARC site 6
πΊπΈGilbert, Arizona, United States
SPARC Site 70
πΊπΈMiami, Florida, United States
SPARC Site 64
πΊπΈDetroit, Michigan, United States
SPARC Site 13
πΊπΈSalt Lake City, Utah, United States
SPARC Site 57
πΊπΈHartford, Connecticut, United States
SPARC Site 10
πΊπΈNew London, Connecticut, United States
SPARC Site 60
πΊπΈWashington, District of Columbia, United States
SPARC Site 9
πΊπΈDerby, Connecticut, United States
SPARC site 83
ππΊBudapest, Hungary
SPARC Site 40
πΊπΈPhoenix, Arizona, United States
SPARC Site 29
πΊπΈIndian Land, South Carolina, United States
SPARC Site 81
ππΊEger, Hungary
SPARC Site 27
πΊπΈBaton Rouge, Louisiana, United States
SPARC Site 86
π·πΊNovosibirsk, Russian Federation
SPARC Site 84
π·πΊSestroretsk, Russian Federation
SPARC Site 55
πΊπΈStratford, New Jersey, United States
SPARC Site 73
πΊπΈNew Orleans, Louisiana, United States
SPARC Site 85
π·πΊSaint Petersburg, Russian Federation
SPARC Site 74
πΊπΈHuntington, West Virginia, United States
SPARC Site 87
π·πΊMoscow, Russian Federation
SPARC Site 91
πΊπ¦Poltava, Ukraine
SPARC Site 89
πΊπ¦Zaporozh'ye, Ukraine
SPARC Site 21
πΊπΈDenver, Colorado, United States
SPARC Site 38
πΊπΈBasalt, Colorado, United States
SPARC Site 54
πΊπΈJacksonville, Florida, United States
SPARC Site 41
πΊπΈMaitland, Florida, United States
SPARC Site 31
πΊπΈSunrise, Florida, United States
SPARC Site 39
πΊπΈTampa, Florida, United States
SPARC Site 51
πΊπΈLenexa, Kansas, United States
SPARC Site 65
πΊπΈTampa, Florida, United States
SPARC Site 50
πΊπΈLouisville, Kentucky, United States
SPARC Site 42
πΊπΈAlexandria, Louisiana, United States
SPARC Site 23
πΊπΈSpringfield, Massachusetts, United States
SPARC Site 35
πΊπΈFoxboro, Massachusetts, United States
SPARC Site 32
πΊπΈClinton Township, Michigan, United States
SPARC Site 5
πΊπΈHenderson, Nevada, United States
SPARC Site 25
πΊπΈGolden Valley, Minnesota, United States
SPARC site 34
πΊπΈFlemington, New Jersey, United States
SPARC Site 49
πΊπΈRochester, New York, United States
SPARC Site 45
πΊπΈCharlotte, North Carolina, United States
SPARC Site 22
πΊπΈAlbuquerque, New Mexico, United States
SPARC Site 4
πΊπΈCharlotte, North Carolina, United States
SPARC Site 24
πΊπΈGreensboro, North Carolina, United States
SPARC Site 2
πΊπΈWinston-Salem, North Carolina, United States
SPARC Site 75
πΊπΈWinston-Salem, North Carolina, United States
SPARC Site 16
πΊπΈAkron, Ohio, United States
SPARC Site 33
πΊπΈCenterville, Ohio, United States
SPARC Site 12
πΊπΈEugene, Oregon, United States
SPARC Site 26
πΊπΈTacoma, Washington, United States
SPARC Site 7
πΊπΈAustin, Texas, United States
SPARC Site 68
πΊπΈAbington, Pennsylvania, United States
SPARC Site 44
πΊπΈSpringfield, Oregon, United States
SPARC Site 71
πΊπΈDallas, Texas, United States
SPARC Site 67
πΊπΈWaukesha, Wisconsin, United States
SPARC Site 69
πΊπΈMilwaukee, Wisconsin, United States
SPARC Site 78
π©πͺWesterstede, Germany
SPARC Site 77
π©πͺDresden, Germany
SPARC Site 79
π©πͺTeupitz, Germany
SPARC Site 82
ππΊBudapest, Hungary
SPARC Site 80
ππΊEsztergom, Hungary
SPARC Site 88
π·πΊStavropol', Russian Federation
SPARC Site 90
πΊπ¦Dnipropetrovsk, Ukraine
SPARC Site 92
πΊπ¦L'viv, Ukraine
SPARC Site 8
πΊπΈOrmond Beach, Florida, United States